JaffeR WLFacchettiF. Tumors Derived From Langerhans Cells. 4th ed.Lyon, France: International Agency for Research on Cancer; 2008.
2.
GhosnMGHaddadACNassarMNAbadjianGAEl KarakFRAftimosPG. Acute myeloid leukemia and Langerhans’ cell histiocytosis: multiple theories for an unusual presentation. Leuk Res. 2010;34:406-408.
3.
EgelerRMNegliaJPPuccettiDMBrennanCANesbitME. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer. 1993;71:865-873.
4.
CastroECBlazquezCBoydJ. Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature. Pediatr Dev Pathol. 2010;13:225-237.
5.
EgelerRMNegliaJPAricòMFavaraBEHeitgerANesbitME. Acute leukemia in association with Langerhans cell histiocytosis. Med Pediatr Oncol. 1994;23:81-85.
6.
AricòMComelliABossiGRaiteriEPiomboMEgelerRM. Langerhans cell histiocytosis and acute leukemia: unusual association in two cases. Med Pediatr Oncol. 1993;21:271-273.
7.
HauptRComelliARosandaCSessaregoMDe BernardiB. Acute myeloid leukemia after single-agent treatment with etoposide for Langerhans’ cell histiocytosis of bone. Am J Pediatr Hematol Oncol. 1993;15:255-257.
8.
MatsuzakiAInamitsuTWatanabeT. Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis. Br J Haematol. 1994;86:887-889.
9.
StineKCSaylorsRLSawyerJRBectonDL. Secondary acute myelogenous leukemia following safe exposure to etoposide. J Clin Oncol. 1997;15:1583-1586.
10.
EgelerRMNegliaJPAricòM. The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society. Hematol Oncol Clin North Am. 1998;12:369-378.
11.
OkuboTAsouNSuzushimaH. Reactive histiocytosis during initial remission induction therapy for acute myeloblastic leukemia [in Japanese]. Rinsho Ketsueki. 1992;33:1824-1828.
12.
HauptRFearsTRHeiseA. Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans’ cell histiocytosis in Italian and Austrian-German populations. Int J Cancer. 1997;71:9-13.
13.
MiseryLGuyotatDCambazardF. Association of Langerhans-cell histiocytosis and acute monocytic leukemia [in French]. Ann Dermatol Venereol. 1998;125:732-733.
14.
MiseryLCamposLDezutter-DambuyantC. CD1-reactive leukemic cells in bone marrow: presence of Langerhans cell marker on leukemic monocytic cells. Eur J Haematol. 1992;48:27-32.
15.
FeldmanALArberDAPittalugaS. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood. 2008;111:5433-5439.
16.
AkashiKTraverDMiyamotoTWeissmanIL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404:193-197.
17.
Schmitt-GraeffAHDuerkopHVollmer-KaryB. Clonal relationship between langerhans cell histiocytosis and myeloid sarcoma. Leukemia. 2012;26:1707-1710.
18.
FeldmanALBertholdFArceciRJ. Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis. Lancet Oncol. 2005;6:435-437.
